APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Ophthalmic Drug Delivery Device

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Ophthalmic Drug Delivery Device Market Outlook and Growth Opportunities 2026

4 July 2026209 pages

Choose your research edition.

Industry ResearchOphthalmic Drug Delivery Device Industry Research Report 2026131 pages · $2,950 USDIndustry Growth & TrendsGlobal Ophthalmic Drug Delivery Device Industry Growth and Trends Forecast to 2032117 pages · $3,450 USDMarket StructureGlobal Ophthalmic Drug Delivery Device Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Ophthalmic Drug Delivery Device Market Outlook and Growth Opportunities 2026209 pages · $4,250 USDMarket Analysis & ForecastGlobal Ophthalmic Drug Delivery Device Market Analysis and Forecast 2026-2032200 pages · $4,950 USD

Market perspective

The global Ophthalmic Drug Delivery Device market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Ophthalmic Drug Delivery Device is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Ophthalmic Drug Delivery Device is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Ophthalmic Drug Delivery Device is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Ophthalmic Drug Delivery Device market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Ophthalmic Drug Delivery Device market include West Pharmaceutical Services, Inc., Terumo Corporation, Silgan Holdings Inc., Re-Vana Therapeutics, Owen Mumford, Ocumedic, Inc., Ocular Therapeutix, Nipro Corporation and Nemera, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Ophthalmic Drug Delivery Device market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Ophthalmic Drug Delivery Device and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Ophthalmic Drug Delivery Device sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Ophthalmic Drug Delivery Device market size, projected growth trends, production technologies, key applications, and end-use industries.

Ophthalmic Drug Delivery Device Segment by Company

West Pharmaceutical Services, Inc.

Terumo Corporation

Silgan Holdings Inc.

Re-Vana Therapeutics

Owen Mumford

Ocumedic, Inc.

Ocular Therapeutix

Nipro Corporation

Nemera

Mati Therapeutics, Inc.,

Kedalion Therapeutics

Gerresheimer

Gaplast GmbH

EyePoint Pharmaceuticals, Inc.

Biocorp Production

Becton Dickinson & Company

Bausch Health

AptarGroup

Aero Pump GmbH

Ophthalmic Drug Delivery Device Segment by Type

Multidose Eyedroppers

Add-On Devices

Squeeze Dispenser

Mist Sprayers

Contact Lenses

Pre-Filled Syringes

Others

Ophthalmic Drug Delivery Device Segment by Application

Clinics

Hospitals

Homecare

Others

Ophthalmic Drug Delivery Device Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Ophthalmic Drug Delivery Device status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Ophthalmic Drug Delivery Device market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Ophthalmic Drug Delivery Device significant trends, drivers, influence factors in global and regions.

6. To analyze Ophthalmic Drug Delivery Device competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Ophthalmic Drug Delivery Device market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Ophthalmic Drug Delivery Device and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Ophthalmic Drug Delivery Device.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Ophthalmic Drug Delivery Device market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Ophthalmic Drug Delivery Device industry.

Chapter 3: Detailed analysis of Ophthalmic Drug Delivery Device manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Ophthalmic Drug Delivery Device in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Ophthalmic Drug Delivery Device in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Ophthalmic Drug Delivery Device Industry Trends Table 2. Ophthalmic Drug Delivery Device Industry Drivers Table 3. Ophthalmic Drug Delivery Device Industry Opportunities and Challenges Table 4. Ophthalmic Drug Delivery Device Industry Restraints Table 5. Global Ophthalmic Drug Delivery Device Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Ophthalmic Drug Delivery Device Revenue Share by Company (2021-2026) Table 7. Global Ophthalmic Drug Delivery Device Sales Volume by Company (k units) & (2021-2026) Table 8. Global Ophthalmic Drug Delivery Device Sales Volume Share by Company (2021-2026) Table 9. Global Ophthalmic Drug Delivery Device Average Price (USD/unit) of Company (2021-2026) Table 10. Global Ophthalmic Drug Delivery Device Company Ranking, (2024-2026) & (USD Million) Table 11. Global Ophthalmic Drug Delivery Device Key Company Manufacturing Base & Headquarters Table 12. Global Ophthalmic Drug Delivery Device Company, Product Type & Application Table 13. Global Ophthalmic Drug Delivery Device Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Ophthalmic Drug Delivery Device by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Multidose Eyedroppers Table 18. Significant Companies of Add-On Devices Table 19. Significant Companies of Squeeze Dispenser Table 20. Significant Companies of Mist Sprayers Table 21. Significant Companies of Contact Lenses Table 22. Significant Companies of Pre-Filled Syringes Table 23. Significant Companies of Others Table 24. Global Ophthalmic Drug Delivery Device Sales Volume by Type 2021 VS 2025 VS 2032 (k units) Table 25. Global Ophthalmic Drug Delivery Device Sales Volume by Type (2021-2026) & (k units) Table 26. Global Ophthalmic Drug Delivery Device Sales Volume by Type (2027-2032) & (k units) Table 27. Global Ophthalmic Drug Delivery Device Sales Volume Share by Type (2021-2026) Table 28. Global Ophthalmic Drug Delivery Device Sales Volume Share by Type (2027-2032) Table 29. Global Ophthalmic Drug Delivery Device Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 30. Global Ophthalmic Drug Delivery Device Sales Value by Type (2021-2026) & (US$ Million) Table 31. Global Ophthalmic Drug Delivery Device Sales Value by Type (2027-2032) & (US$ Million) Table 32. Global Ophthalmic Drug Delivery Device Sales Value Share by Type (2021-2026) Table 33. Global Ophthalmic Drug Delivery Device Sales Value Share by Type (2027-2032) Table 34. Significant Companies of Clinics Table 35. Significant Companies of Hospitals Table 36. Significant Companies of Homecare Table 37. Significant Companies of Others Table 38. Global Ophthalmic Drug Delivery Device Sales Volume by Application 2021 VS 2025 VS 2032 (k units) Table 39. Global Ophthalmic Drug Delivery Device Sales Volume by Application (2021-2026) & (k units) Table 40. Global Ophthalmic Drug Delivery Device Sales Volume by Application (2027-2032) & (k units) Table 41. Global Ophthalmic Drug Delivery Device Sales Volume Share by Application (2021-2026) Table 42. Global Ophthalmic Drug Delivery Device Sales Volume Share by Application (2027-2032) Table 43. Global Ophthalmic Drug Delivery Device Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 44. Global Ophthalmic Drug Delivery Device Sales Value by Application (2021-2026) & (US$ Million) Table 45. Global Ophthalmic Drug Delivery Device Sales Value by Application (2027-2032) & (US$ Million) Table 46. Global Ophthalmic Drug Delivery Device Sales Value Share by Application (2021-2026) Table 47. Global Ophthalmic Drug Delivery Device Sales Value Share by Application (2027-2032) Table 48. Global Ophthalmic Drug Delivery Device Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 49. Global Ophthalmic Drug Delivery Device Sales by Region (2021-2026) & (k units) Table 50. Global Ophthalmic Drug Delivery Device Sales Market Share by Region (2021-2026) Table 51. Global Ophthalmic Drug Delivery Device Sales by Region (2027-2032) & (k units) Table 52. Global Ophthalmic Drug Delivery Device Sales Market Share by Region (2027-2032) Table 53. Global Ophthalmic Drug Delivery Device Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 54. Global Ophthalmic Drug Delivery Device Sales Value by Region (2021-2026) & (US$ Million) Table 55. Global Ophthalmic Drug Delivery Device Sales Value Share by Region (2021-2026) Table 56. Global Ophthalmic Drug Delivery Device Sales Value by Region (2027-2032) & (US$ Million) Table 57. Global Ophthalmic Drug Delivery Device Sales Value Share by Region (2027-2032) Table 58. Global Ophthalmic Drug Delivery Device Market Average Price (USD/unit) by Region (2021-2026) Table 59. Global Ophthalmic Drug Delivery Device Market Average Price (USD/unit) by Region (2027-2032) Table 60. Global Ophthalmic Drug Delivery Device Sales by Country: 2021 VS 2025 VS 2032 (k units) Table 61. Global Ophthalmic Drug Delivery Device Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 62. Global Ophthalmic Drug Delivery Device Sales by Country (2021-2026) & (k units) Table 63. Global Ophthalmic Drug Delivery Device Sales Market Share by Country (2021-2026) Table 64. Global Ophthalmic Drug Delivery Device Sales by Country (2027-2032) & (k units) Table 65. Global Ophthalmic Drug Delivery Device Sales Market Share by Country (2027-2032) Table 66. Global Ophthalmic Drug Delivery Device Sales Value by Country (2021-2026) & (US$ Million) Table 67. Global Ophthalmic Drug Delivery Device Sales Value Market Share by Country (2021-2026) Table 68. Global Ophthalmic Drug Delivery Device Sales Value by Country (2027-2032) & (US$ Million) Table 69. Global Ophthalmic Drug Delivery Device Sales Value Market Share by Country (2027-2032) Table 70. West Pharmaceutical Services, Inc. Company Information Table 71. West Pharmaceutical Services, Inc. Business Overview Table 72. West Pharmaceutical Services, Inc. Ophthalmic Drug Delivery Device Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 73. West Pharmaceutical Services, Inc. Ophthalmic Drug Delivery Device Product Portfolio Table 74. West Pharmaceutical Services, Inc. Recent Development Table 75. Terumo Corporation Company Information Table 76. Terumo Corporation Business Overview Table 77. Terumo Corporation Ophthalmic Drug Delivery Device Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 78. Terumo Corporation Ophthalmic Drug Delivery Device Product Portfolio Table 79. Terumo Corporation Recent Development Table 80. Silgan Holdings Inc. Company Information Table 81. Silgan Holdings Inc. Business Overview Table 82. Silgan Holdings Inc. Ophthalmic Drug Delivery Device Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 83. Silgan Holdings Inc. Ophthalmic Drug Delivery Device Product Portfolio Table 84. Silgan Holdings Inc. Recent Development Table 85. Re-Vana Therapeutics Company Information Table 86. Re-Vana Therapeutics Business Overview Table 87. Re-Vana Therapeutics Ophthalmic Drug Delivery Device Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 88. Re-Vana Therapeutics Ophthalmic Drug Delivery Device Product Portfolio Table 89. Re-Vana Therapeutics Recent Development Table 90. Owen Mumford Company Information Table 91. Owen Mumford Business Overview Table 92. Owen Mumford Ophthalmic Drug Delivery Device Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 93. Owen Mumford Ophthalmic Drug Delivery Device Product Portfolio Table 94. Owen Mumford Recent Development Table 95. Ocumedic, Inc. Company Information Table 96. Ocumedic, Inc. Business Overview Table 97. Ocumedic, Inc. Ophthalmic Drug Delivery Device Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 98. Ocumedic, Inc. Ophthalmic Drug Delivery Device Product Portfolio Table 99. Ocumedic, Inc. Recent Development Table 100. Ocular Therapeutix Company Information Table 101. Ocular Therapeutix Business Overview Table 102. Ocular Therapeutix Ophthalmic Drug Delivery Device Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 103. Ocular Therapeutix Ophthalmic Drug Delivery Device Product Portfolio Table 104. Ocular Therapeutix Recent Development Table 105. Nipro Corporation Company Information Table 106. Nipro Corporation Business Overview Table 107. Nipro Corporation Ophthalmic Drug Delivery Device Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 108. Nipro Corporation Ophthalmic Drug Delivery Device Product Portfolio Table 109. Nipro Corporation Recent Development Table 110. Nemera Company Information Table 111. Nemera Business Overview Table 112. Nemera Ophthalmic Drug Delivery Device Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 113. Nemera Ophthalmic Drug Delivery Device Product Portfolio Table 114. Nemera Recent Development Table 115. Mati Therapeutics, Inc., Company Information Table 116. Mati Therapeutics, Inc., Business Overview Table 117. Mati Therapeutics, Inc., Ophthalmic Drug Delivery Device Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 118. Mati Therapeutics, Inc., Ophthalmic Drug Delivery Device Product Portfolio Table 119. Mati Therapeutics, Inc., Recent Development Table 120. Kedalion Therapeutics Company Information Table 121. Kedalion Therapeutics Business Overview Table 122. Kedalion Therapeutics Ophthalmic Drug Delivery Device Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 123. Kedalion Therapeutics Ophthalmic Drug Delivery Device Product Portfolio Table 124. Kedalion Therapeutics Recent Development Table 125. Gerresheimer Company Information Table 126. Gerresheimer Business Overview Table 127. Gerresheimer Ophthalmic Drug Delivery Device Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 128. Gerresheimer Ophthalmic Drug Delivery Device Product Portfolio Table 129. Gerresheimer Recent Development Table 130. Gaplast GmbH Company Information Table 131. Gaplast GmbH Business Overview Table 132. Gaplast GmbH Ophthalmic Drug Delivery Device Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 133. Gaplast GmbH Ophthalmic Drug Delivery Device Product Portfolio Table 134. Gaplast GmbH Recent Development Table 135. EyePoint Pharmaceuticals, Inc. Company Information Table 136. EyePoint Pharmaceuticals, Inc. Business Overview Table 137. EyePoint Pharmaceuticals, Inc. Ophthalmic Drug Delivery Device Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 138. EyePoint Pharmaceuticals, Inc. Ophthalmic Drug Delivery Device Product Portfolio Table 139. EyePoint Pharmaceuticals, Inc. Recent Development Table 140. Biocorp Production Company Information Table 141. Biocorp Production Business Overview Table 142. Biocorp Production Ophthalmic Drug Delivery Device Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 143. Biocorp Production Ophthalmic Drug Delivery Device Product Portfolio Table 144. Biocorp Production Recent Development Table 145. Becton Dickinson & Company Company Information Table 146. Becton Dickinson & Company Business Overview Table 147. Becton Dickinson & Company Ophthalmic Drug Delivery Device Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 148. Becton Dickinson & Company Ophthalmic Drug Delivery Device Product Portfolio Table 149. Becton Dickinson & Company Recent Development Table 150. Bausch Health Company Information Table 151. Bausch Health Business Overview Table 152. Bausch Health Ophthalmic Drug Delivery Device Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 153. Bausch Health Ophthalmic Drug Delivery Device Product Portfolio Table 154. Bausch Health Recent Development Table 155. AptarGroup Company Information Table 156. AptarGroup Business Overview Table 157. AptarGroup Ophthalmic Drug Delivery Device Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 158. AptarGroup Ophthalmic Drug Delivery Device Product Portfolio Table 159. AptarGroup Recent Development Table 160. Aero Pump GmbH Company Information Table 161. Aero Pump GmbH Business Overview Table 162. Aero Pump GmbH Ophthalmic Drug Delivery Device Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 163. Aero Pump GmbH Ophthalmic Drug Delivery Device Product Portfolio Table 164. Aero Pump GmbH Recent Development Table 165. Key Raw Materials Table 166. Raw Materials Key Suppliers Table 167. Ophthalmic Drug Delivery Device Distributors List Table 168. Ophthalmic Drug Delivery Device Customers List Table 169. Research Programs/Design for This Report Table 170. Authors List of This Report Table 171. Secondary Sources Table 172. Primary Sources List of Figures Figure 1. Ophthalmic Drug Delivery Device Product Image Figure 2. Global Ophthalmic Drug Delivery Device Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Ophthalmic Drug Delivery Device Sales Value (2021-2032) & (US$ Million) Figure 4. Global Ophthalmic Drug Delivery Device Sales (2021-2032) & (k units) Figure 5. Global Ophthalmic Drug Delivery Device Sales Average Price (USD/unit) & (2021-2032) Figure 6. Global Ophthalmic Drug Delivery Device Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Multidose Eyedroppers Image Figure 10. Add-On Devices Image Figure 11. Squeeze Dispenser Image Figure 12. Mist Sprayers Image Figure 13. Contact Lenses Image Figure 14. Pre-Filled Syringes Image Figure 15. Others Image Figure 16. Global Ophthalmic Drug Delivery Device Sales Volume by Type (2021 VS 2025 VS 2032) & (k units) Figure 17. Global Ophthalmic Drug Delivery Device Sales Volume Share 2021 VS 2025 VS 2032 Figure 18. Global Ophthalmic Drug Delivery Device Sales Volume Share by Type (2021-2032) Figure 19. Global Ophthalmic Drug Delivery Device Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 20. Global Ophthalmic Drug Delivery Device Sales Value Share 2021 VS 2025 VS 2032 Figure 21. Global Ophthalmic Drug Delivery Device Sales Value Share by Type (2021-2032) Figure 22. Clinics Image Figure 23. Hospitals Image Figure 24. Homecare Image Figure 25. Others Image Figure 26. Global Ophthalmic Drug Delivery Device Sales Volume by Application (2021 VS 2025 VS 2032) & (k units) Figure 27. Global Ophthalmic Drug Delivery Device Sales Volume Share 2021 VS 2025 VS 2032 Figure 28. Global Ophthalmic Drug Delivery Device Sales Volume Share by Application (2021-2032) Figure 29. Global Ophthalmic Drug Delivery Device Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 30. Global Ophthalmic Drug Delivery Device Sales Value Share 2021 VS 2025 VS 2032 Figure 31. Global Ophthalmic Drug Delivery Device Sales Value Share by Application (2021-2032) Figure 32. Global Ophthalmic Drug Delivery Device Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 33. Global Ophthalmic Drug Delivery Device Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 34. Global Ophthalmic Drug Delivery Device Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 35. Global Ophthalmic Drug Delivery Device Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 36. North America Ophthalmic Drug Delivery Device Sales Value (2021-2032) & (US$ Million) Figure 37. North America Ophthalmic Drug Delivery Device Sales Value Share by Country (%), 2025 VS 2032 Figure 38. Europe Ophthalmic Drug Delivery Device Sales Value (2021-2032) & (US$ Million) Figure 39. Europe Ophthalmic Drug Delivery Device Sales Value Share by Country (%), 2025 VS 2032 Figure 40. Asia-Pacific Ophthalmic Drug Delivery Device Sales Value (2021-2032) & (US$ Million) Figure 41. Asia-Pacific Ophthalmic Drug Delivery Device Sales Value Share by Country (%), 2025 VS 2032 Figure 42. South America Ophthalmic Drug Delivery Device Sales Value (2021-2032) & (US$ Million) Figure 43. South America Ophthalmic Drug Delivery Device Sales Value Share by Country (%), 2025 VS 2032 Figure 44. Middle East & Africa Ophthalmic Drug Delivery Device Sales Value (2021-2032) & (US$ Million) Figure 45. Middle East & Africa Ophthalmic Drug Delivery Device Sales Value Share by Country (%), 2025 VS 2032 Figure 46. USA Ophthalmic Drug Delivery Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. USA Ophthalmic Drug Delivery Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. USA Ophthalmic Drug Delivery Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Canada Ophthalmic Drug Delivery Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Canada Ophthalmic Drug Delivery Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Canada Ophthalmic Drug Delivery Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. Mexico Ophthalmic Drug Delivery Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. Mexico Ophthalmic Drug Delivery Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. Mexico Ophthalmic Drug Delivery Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. Germany Ophthalmic Drug Delivery Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. Germany Ophthalmic Drug Delivery Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. Germany Ophthalmic Drug Delivery Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. France Ophthalmic Drug Delivery Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. France Ophthalmic Drug Delivery Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. France Ophthalmic Drug Delivery Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. U.K. Ophthalmic Drug Delivery Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. U.K. Ophthalmic Drug Delivery Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. U.K. Ophthalmic Drug Delivery Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Italy Ophthalmic Drug Delivery Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Italy Ophthalmic Drug Delivery Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Italy Ophthalmic Drug Delivery Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Spain Ophthalmic Drug Delivery Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Spain Ophthalmic Drug Delivery Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Spain Ophthalmic Drug Delivery Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Russia Ophthalmic Drug Delivery Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Russia Ophthalmic Drug Delivery Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Russia Ophthalmic Drug Delivery Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. Netherlands Ophthalmic Drug Delivery Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. Netherlands Ophthalmic Drug Delivery Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. Netherlands Ophthalmic Drug Delivery Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Nordic Countries Ophthalmic Drug Delivery Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Nordic Countries Ophthalmic Drug Delivery Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Nordic Countries Ophthalmic Drug Delivery Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. China Ophthalmic Drug Delivery Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. China Ophthalmic Drug Delivery Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. China Ophthalmic Drug Delivery Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. Japan Ophthalmic Drug Delivery Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. Japan Ophthalmic Drug Delivery Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. Japan Ophthalmic Drug Delivery Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. South Korea Ophthalmic Drug Delivery Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. South Korea Ophthalmic Drug Delivery Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. South Korea Ophthalmic Drug Delivery Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. India Ophthalmic Drug Delivery Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. India Ophthalmic Drug Delivery Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. India Ophthalmic Drug Delivery Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Australia Ophthalmic Drug Delivery Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Australia Ophthalmic Drug Delivery Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Australia Ophthalmic Drug Delivery Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Southeast Asia Ophthalmic Drug Delivery Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Southeast Asia Ophthalmic Drug Delivery Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Southeast Asia Ophthalmic Drug Delivery Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Brazil Ophthalmic Drug Delivery Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Brazil Ophthalmic Drug Delivery Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Brazil Ophthalmic Drug Delivery Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Argentina Ophthalmic Drug Delivery Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Argentina Ophthalmic Drug Delivery Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Argentina Ophthalmic Drug Delivery Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Chile Ophthalmic Drug Delivery Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Chile Ophthalmic Drug Delivery Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Chile Ophthalmic Drug Delivery Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Colombia Ophthalmic Drug Delivery Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Colombia Ophthalmic Drug Delivery Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Colombia Ophthalmic Drug Delivery Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Peru Ophthalmic Drug Delivery Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Peru Ophthalmic Drug Delivery Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Peru Ophthalmic Drug Delivery Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. Saudi Arabia Ophthalmic Drug Delivery Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. Saudi Arabia Ophthalmic Drug Delivery Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. Saudi Arabia Ophthalmic Drug Delivery Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Israel Ophthalmic Drug Delivery Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. Israel Arabia Ophthalmic Drug Delivery Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. Israel Arabia Ophthalmic Drug Delivery Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. UAE Ophthalmic Drug Delivery Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. UAE Ophthalmic Drug Delivery Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. UAE Ophthalmic Drug Delivery Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Turkey Ophthalmic Drug Delivery Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Turkey Ophthalmic Drug Delivery Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Turkey Ophthalmic Drug Delivery Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Iran Ophthalmic Drug Delivery Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 125. Iran Ophthalmic Drug Delivery Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 126. Iran Ophthalmic Drug Delivery Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 127. Egypt Ophthalmic Drug Delivery Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 128. Egypt Ophthalmic Drug Delivery Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 129. Egypt Ophthalmic Drug Delivery Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 130. Ophthalmic Drug Delivery Device Value Chain Figure 131. Manufacturing Cost Structure Figure 132. Ophthalmic Drug Delivery Device Sales Mode & Process Figure 133. Direct Comparison with Distribution Share Figure 134. Distributors Profiles Figure 135. Years Considered Figure 136. Research Process Figure 137. Key Executives Interviewed

Scope & coverage.

Types
  • Multidose Eyedroppers
  • Add-On Devices
  • Squeeze Dispenser
  • Mist Sprayers
  • Contact Lenses
  • Pre-Filled Syringes
  • Others
Applications
  • Clinics
  • Hospitals
  • Homecare
  • Others
Companies covered
  • West Pharmaceutical Services, Inc.
  • Terumo Corporation
  • Silgan Holdings Inc.
  • Re-Vana Therapeutics
  • Owen Mumford
  • Ocumedic, Inc.
  • Ocular Therapeutix
  • Nipro Corporation
  • Nemera
  • Mati Therapeutics, Inc.,
  • Kedalion Therapeutics
  • Gerresheimer
  • Gaplast GmbH
  • EyePoint Pharmaceuticals, Inc.
  • Biocorp Production
  • Becton Dickinson & Company
  • Bausch Health
  • AptarGroup
  • Aero Pump GmbH

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Ophthalmic Drug Delivery Device Sales Value (2021-2032)
  4. 1.2.2 Global Ophthalmic Drug Delivery Device Sales Volume (2021-2032)
  5. 1.2.3 Global Ophthalmic Drug Delivery Device Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Ophthalmic Drug Delivery Device Market Dynamics
  1. 2.1 Ophthalmic Drug Delivery Device Industry Trends
  2. 2.2 Ophthalmic Drug Delivery Device Industry Drivers
  3. 2.3 Ophthalmic Drug Delivery Device Industry Opportunities and Challenges
  4. 2.4 Ophthalmic Drug Delivery Device Industry Restraints
3 Ophthalmic Drug Delivery Device Market by Company
  1. 3.1 Global Ophthalmic Drug Delivery Device Company Revenue Ranking in 2025
  2. 3.2 Global Ophthalmic Drug Delivery Device Revenue by Company (2021-2026)
  3. 3.3 Global Ophthalmic Drug Delivery Device Sales Volume by Company (2021-2026)
  4. 3.4 Global Ophthalmic Drug Delivery Device Average Price by Company (2021-2026)
  5. 3.5 Global Ophthalmic Drug Delivery Device Company Ranking (2024-2026)
  6. 3.6 Global Ophthalmic Drug Delivery Device Company Manufacturing Base and Headquarters
  7. 3.7 Global Ophthalmic Drug Delivery Device Company Product Type and Application
  8. 3.8 Global Ophthalmic Drug Delivery Device Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Ophthalmic Drug Delivery Device Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Ophthalmic Drug Delivery Device Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Ophthalmic Drug Delivery Device Market by Type
  1. 4.1 Ophthalmic Drug Delivery Device Type Introduction
  2. 4.1.1 Multidose Eyedroppers
  3. 4.1.2 Add-On Devices
  4. 4.1.3 Squeeze Dispenser
  5. 4.1.4 Mist Sprayers
  6. 4.1.5 Contact Lenses
  7. 4.1.6 Pre-Filled Syringes
  8. 4.1.7 Others
  9. 4.2 Global Ophthalmic Drug Delivery Device Sales Volume by Type
  10. 4.2.1 Global Ophthalmic Drug Delivery Device Sales Volume by Type (2021 VS 2025 VS 2032)
  11. 4.2.2 Global Ophthalmic Drug Delivery Device Sales Volume by Type (2021-2032)
  12. 4.2.3 Global Ophthalmic Drug Delivery Device Sales Volume Share by Type (2021-2032)
  13. 4.3 Global Ophthalmic Drug Delivery Device Sales Value by Type
  14. 4.3.1 Global Ophthalmic Drug Delivery Device Sales Value by Type (2021 VS 2025 VS 2032)
  15. 4.3.2 Global Ophthalmic Drug Delivery Device Sales Value by Type (2021-2032)
  16. 4.3.3 Global Ophthalmic Drug Delivery Device Sales Value Share by Type (2021-2032)
5 Ophthalmic Drug Delivery Device Market by Application
  1. 5.1 Ophthalmic Drug Delivery Device Application Introduction
  2. 5.1.1 Clinics
  3. 5.1.2 Hospitals
  4. 5.1.3 Homecare
  5. 5.1.4 Others
  6. 5.2 Global Ophthalmic Drug Delivery Device Sales Volume by Application
  7. 5.2.1 Global Ophthalmic Drug Delivery Device Sales Volume by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Ophthalmic Drug Delivery Device Sales Volume by Application (2021-2032)
  9. 5.2.3 Global Ophthalmic Drug Delivery Device Sales Volume Share by Application (2021-2032)
  10. 5.3 Global Ophthalmic Drug Delivery Device Sales Value by Application
  11. 5.3.1 Global Ophthalmic Drug Delivery Device Sales Value by Application (2021 VS 2025 VS 2032)
  12. 5.3.2 Global Ophthalmic Drug Delivery Device Sales Value by Application (2021-2032)
  13. 5.3.3 Global Ophthalmic Drug Delivery Device Sales Value Share by Application (2021-2032)
6 Ophthalmic Drug Delivery Device Regional Sales and Value Analysis
  1. 6.1 Global Ophthalmic Drug Delivery Device Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Ophthalmic Drug Delivery Device Sales by Region (2021-2032)
  3. 6.2.1 Global Ophthalmic Drug Delivery Device Sales by Region: 2021-2026
  4. 6.2.2 Global Ophthalmic Drug Delivery Device Sales by Region (2027-2032)
  5. 6.3 Global Ophthalmic Drug Delivery Device Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Ophthalmic Drug Delivery Device Sales Value by Region (2021-2032)
  7. 6.4.1 Global Ophthalmic Drug Delivery Device Sales Value by Region: 2021-2026
  8. 6.4.2 Global Ophthalmic Drug Delivery Device Sales Value by Region (2027-2032)
  9. 6.5 Global Ophthalmic Drug Delivery Device Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Ophthalmic Drug Delivery Device Sales Value (2021-2032)
  12. 6.6.2 North America Ophthalmic Drug Delivery Device Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Ophthalmic Drug Delivery Device Sales Value (2021-2032)
  15. 6.7.2 Europe Ophthalmic Drug Delivery Device Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Ophthalmic Drug Delivery Device Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Ophthalmic Drug Delivery Device Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Ophthalmic Drug Delivery Device Sales Value (2021-2032)
  21. 6.9.2 South America Ophthalmic Drug Delivery Device Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Ophthalmic Drug Delivery Device Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Ophthalmic Drug Delivery Device Sales Value Share by Country, 2025 VS 2032
7 Ophthalmic Drug Delivery Device Country-level Sales and Value Analysis
  1. 7.1 Global Ophthalmic Drug Delivery Device Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Ophthalmic Drug Delivery Device Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Ophthalmic Drug Delivery Device Sales by Country (2021-2032)
  4. 7.3.1 Global Ophthalmic Drug Delivery Device Sales by Country (2021-2026)
  5. 7.3.2 Global Ophthalmic Drug Delivery Device Sales by Country (2027-2032)
  6. 7.4 Global Ophthalmic Drug Delivery Device Sales Value by Country (2021-2032)
  7. 7.4.1 Global Ophthalmic Drug Delivery Device Sales Value by Country (2021-2026)
  8. 7.4.2 Global Ophthalmic Drug Delivery Device Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Ophthalmic Drug Delivery Device Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Ophthalmic Drug Delivery Device Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Ophthalmic Drug Delivery Device Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Ophthalmic Drug Delivery Device Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Ophthalmic Drug Delivery Device Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Ophthalmic Drug Delivery Device Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Ophthalmic Drug Delivery Device Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Ophthalmic Drug Delivery Device Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Ophthalmic Drug Delivery Device Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Ophthalmic Drug Delivery Device Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Ophthalmic Drug Delivery Device Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Ophthalmic Drug Delivery Device Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Ophthalmic Drug Delivery Device Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Ophthalmic Drug Delivery Device Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Ophthalmic Drug Delivery Device Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Ophthalmic Drug Delivery Device Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Ophthalmic Drug Delivery Device Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Ophthalmic Drug Delivery Device Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Ophthalmic Drug Delivery Device Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Ophthalmic Drug Delivery Device Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Ophthalmic Drug Delivery Device Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Ophthalmic Drug Delivery Device Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Ophthalmic Drug Delivery Device Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Ophthalmic Drug Delivery Device Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Ophthalmic Drug Delivery Device Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Ophthalmic Drug Delivery Device Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Ophthalmic Drug Delivery Device Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Ophthalmic Drug Delivery Device Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Ophthalmic Drug Delivery Device Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Ophthalmic Drug Delivery Device Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Ophthalmic Drug Delivery Device Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Ophthalmic Drug Delivery Device Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Ophthalmic Drug Delivery Device Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Ophthalmic Drug Delivery Device Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Ophthalmic Drug Delivery Device Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Ophthalmic Drug Delivery Device Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Ophthalmic Drug Delivery Device Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Ophthalmic Drug Delivery Device Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Ophthalmic Drug Delivery Device Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Ophthalmic Drug Delivery Device Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Ophthalmic Drug Delivery Device Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Ophthalmic Drug Delivery Device Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Ophthalmic Drug Delivery Device Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Ophthalmic Drug Delivery Device Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Ophthalmic Drug Delivery Device Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Ophthalmic Drug Delivery Device Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Ophthalmic Drug Delivery Device Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Ophthalmic Drug Delivery Device Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Ophthalmic Drug Delivery Device Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Ophthalmic Drug Delivery Device Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Ophthalmic Drug Delivery Device Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Ophthalmic Drug Delivery Device Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Ophthalmic Drug Delivery Device Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Ophthalmic Drug Delivery Device Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Ophthalmic Drug Delivery Device Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Ophthalmic Drug Delivery Device Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Ophthalmic Drug Delivery Device Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Ophthalmic Drug Delivery Device Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Ophthalmic Drug Delivery Device Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Ophthalmic Drug Delivery Device Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Ophthalmic Drug Delivery Device Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Ophthalmic Drug Delivery Device Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Ophthalmic Drug Delivery Device Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Ophthalmic Drug Delivery Device Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Ophthalmic Drug Delivery Device Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Ophthalmic Drug Delivery Device Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Ophthalmic Drug Delivery Device Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Ophthalmic Drug Delivery Device Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Ophthalmic Drug Delivery Device Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Ophthalmic Drug Delivery Device Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Ophthalmic Drug Delivery Device Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Ophthalmic Drug Delivery Device Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Ophthalmic Drug Delivery Device Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Ophthalmic Drug Delivery Device Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Ophthalmic Drug Delivery Device Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Ophthalmic Drug Delivery Device Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Ophthalmic Drug Delivery Device Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Ophthalmic Drug Delivery Device Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Ophthalmic Drug Delivery Device Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Ophthalmic Drug Delivery Device Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Ophthalmic Drug Delivery Device Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Ophthalmic Drug Delivery Device Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Ophthalmic Drug Delivery Device Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Ophthalmic Drug Delivery Device Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 West Pharmaceutical Services, Inc.
  2. 8.1.1 West Pharmaceutical Services, Inc. Company Information
  3. 8.1.2 West Pharmaceutical Services, Inc. Business Overview
  4. 8.1.3 West Pharmaceutical Services, Inc. Ophthalmic Drug Delivery Device Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 West Pharmaceutical Services, Inc. Ophthalmic Drug Delivery Device Product Portfolio
  6. 8.1.5 West Pharmaceutical Services, Inc. Recent Developments
  7. 8.2 Terumo Corporation
  8. 8.2.1 Terumo Corporation Company Information
  9. 8.2.2 Terumo Corporation Business Overview
  10. 8.2.3 Terumo Corporation Ophthalmic Drug Delivery Device Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Terumo Corporation Ophthalmic Drug Delivery Device Product Portfolio
  12. 8.2.5 Terumo Corporation Recent Developments
  13. 8.3 Silgan Holdings Inc.
  14. 8.3.1 Silgan Holdings Inc. Company Information
  15. 8.3.2 Silgan Holdings Inc. Business Overview
  16. 8.3.3 Silgan Holdings Inc. Ophthalmic Drug Delivery Device Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Silgan Holdings Inc. Ophthalmic Drug Delivery Device Product Portfolio
  18. 8.3.5 Silgan Holdings Inc. Recent Developments
  19. 8.4 Re-Vana Therapeutics
  20. 8.4.1 Re-Vana Therapeutics Company Information
  21. 8.4.2 Re-Vana Therapeutics Business Overview
  22. 8.4.3 Re-Vana Therapeutics Ophthalmic Drug Delivery Device Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Re-Vana Therapeutics Ophthalmic Drug Delivery Device Product Portfolio
  24. 8.4.5 Re-Vana Therapeutics Recent Developments
  25. 8.5 Owen Mumford
  26. 8.5.1 Owen Mumford Company Information
  27. 8.5.2 Owen Mumford Business Overview
  28. 8.5.3 Owen Mumford Ophthalmic Drug Delivery Device Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Owen Mumford Ophthalmic Drug Delivery Device Product Portfolio
  30. 8.5.5 Owen Mumford Recent Developments
  31. 8.6 Ocumedic, Inc.
  32. 8.6.1 Ocumedic, Inc. Company Information
  33. 8.6.2 Ocumedic, Inc. Business Overview
  34. 8.6.3 Ocumedic, Inc. Ophthalmic Drug Delivery Device Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Ocumedic, Inc. Ophthalmic Drug Delivery Device Product Portfolio
  36. 8.6.5 Ocumedic, Inc. Recent Developments
  37. 8.7 Ocular Therapeutix
  38. 8.7.1 Ocular Therapeutix Company Information
  39. 8.7.2 Ocular Therapeutix Business Overview
  40. 8.7.3 Ocular Therapeutix Ophthalmic Drug Delivery Device Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Ocular Therapeutix Ophthalmic Drug Delivery Device Product Portfolio
  42. 8.7.5 Ocular Therapeutix Recent Developments
  43. 8.8 Nipro Corporation
  44. 8.8.1 Nipro Corporation Company Information
  45. 8.8.2 Nipro Corporation Business Overview
  46. 8.8.3 Nipro Corporation Ophthalmic Drug Delivery Device Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Nipro Corporation Ophthalmic Drug Delivery Device Product Portfolio
  48. 8.8.5 Nipro Corporation Recent Developments
  49. 8.9 Nemera
  50. 8.9.1 Nemera Company Information
  51. 8.9.2 Nemera Business Overview
  52. 8.9.3 Nemera Ophthalmic Drug Delivery Device Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Nemera Ophthalmic Drug Delivery Device Product Portfolio
  54. 8.9.5 Nemera Recent Developments
  55. 8.10 Mati Therapeutics, Inc.,
  56. 8.10.1 Mati Therapeutics, Inc., Company Information
  57. 8.10.2 Mati Therapeutics, Inc., Business Overview
  58. 8.10.3 Mati Therapeutics, Inc., Ophthalmic Drug Delivery Device Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Mati Therapeutics, Inc., Ophthalmic Drug Delivery Device Product Portfolio
  60. 8.10.5 Mati Therapeutics, Inc., Recent Developments
  61. 8.11 Kedalion Therapeutics
  62. 8.11.1 Kedalion Therapeutics Company Information
  63. 8.11.2 Kedalion Therapeutics Business Overview
  64. 8.11.3 Kedalion Therapeutics Ophthalmic Drug Delivery Device Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 Kedalion Therapeutics Ophthalmic Drug Delivery Device Product Portfolio
  66. 8.11.5 Kedalion Therapeutics Recent Developments
  67. 8.12 Gerresheimer
  68. 8.12.1 Gerresheimer Company Information
  69. 8.12.2 Gerresheimer Business Overview
  70. 8.12.3 Gerresheimer Ophthalmic Drug Delivery Device Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 Gerresheimer Ophthalmic Drug Delivery Device Product Portfolio
  72. 8.12.5 Gerresheimer Recent Developments
  73. 8.13 Gaplast GmbH
  74. 8.13.1 Gaplast GmbH Company Information
  75. 8.13.2 Gaplast GmbH Business Overview
  76. 8.13.3 Gaplast GmbH Ophthalmic Drug Delivery Device Sales, Value and Gross Margin (2021-2026)
  77. 8.13.4 Gaplast GmbH Ophthalmic Drug Delivery Device Product Portfolio
  78. 8.13.5 Gaplast GmbH Recent Developments
  79. 8.14 EyePoint Pharmaceuticals, Inc.
  80. 8.14.1 EyePoint Pharmaceuticals, Inc. Company Information
  81. 8.14.2 EyePoint Pharmaceuticals, Inc. Business Overview
  82. 8.14.3 EyePoint Pharmaceuticals, Inc. Ophthalmic Drug Delivery Device Sales, Value and Gross Margin (2021-2026)
  83. 8.14.4 EyePoint Pharmaceuticals, Inc. Ophthalmic Drug Delivery Device Product Portfolio
  84. 8.14.5 EyePoint Pharmaceuticals, Inc. Recent Developments
  85. 8.15 Biocorp Production
  86. 8.15.1 Biocorp Production Company Information
  87. 8.15.2 Biocorp Production Business Overview
  88. 8.15.3 Biocorp Production Ophthalmic Drug Delivery Device Sales, Value and Gross Margin (2021-2026)
  89. 8.15.4 Biocorp Production Ophthalmic Drug Delivery Device Product Portfolio
  90. 8.15.5 Biocorp Production Recent Developments
  91. 8.16 Becton Dickinson & Company
  92. 8.16.1 Becton Dickinson & Company Company Information
  93. 8.16.2 Becton Dickinson & Company Business Overview
  94. 8.16.3 Becton Dickinson & Company Ophthalmic Drug Delivery Device Sales, Value and Gross Margin (2021-2026)
  95. 8.16.4 Becton Dickinson & Company Ophthalmic Drug Delivery Device Product Portfolio
  96. 8.16.5 Becton Dickinson & Company Recent Developments
  97. 8.17 Bausch Health
  98. 8.17.1 Bausch Health Company Information
  99. 8.17.2 Bausch Health Business Overview
  100. 8.17.3 Bausch Health Ophthalmic Drug Delivery Device Sales, Value and Gross Margin (2021-2026)
  101. 8.17.4 Bausch Health Ophthalmic Drug Delivery Device Product Portfolio
  102. 8.17.5 Bausch Health Recent Developments
  103. 8.18 AptarGroup
  104. 8.18.1 AptarGroup Company Information
  105. 8.18.2 AptarGroup Business Overview
  106. 8.18.3 AptarGroup Ophthalmic Drug Delivery Device Sales, Value and Gross Margin (2021-2026)
  107. 8.18.4 AptarGroup Ophthalmic Drug Delivery Device Product Portfolio
  108. 8.18.5 AptarGroup Recent Developments
  109. 8.19 Aero Pump GmbH
  110. 8.19.1 Aero Pump GmbH Company Information
  111. 8.19.2 Aero Pump GmbH Business Overview
  112. 8.19.3 Aero Pump GmbH Ophthalmic Drug Delivery Device Sales, Value and Gross Margin (2021-2026)
  113. 8.19.4 Aero Pump GmbH Ophthalmic Drug Delivery Device Product Portfolio
  114. 8.19.5 Aero Pump GmbH Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Ophthalmic Drug Delivery Device Value Chain Analysis
  2. 9.1.1 Ophthalmic Drug Delivery Device Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Ophthalmic Drug Delivery Device Sales Mode & Process
  6. 9.2 Ophthalmic Drug Delivery Device Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Ophthalmic Drug Delivery Device Distributors
  9. 9.2.3 Ophthalmic Drug Delivery Device Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst